These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19177822)
1. [Importance of genotyping of thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy]. Dokmanović L; Janić D; Krstovski N; Zukić B; Tosić N; Pavlović S Srp Arh Celok Lek; 2008; 136(11-12):609-16. PubMed ID: 19177822 [TBL] [Abstract][Full Text] [Related]
2. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis. Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286 [TBL] [Abstract][Full Text] [Related]
3. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697 [TBL] [Abstract][Full Text] [Related]
4. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine. Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411 [TBL] [Abstract][Full Text] [Related]
5. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024 [TBL] [Abstract][Full Text] [Related]
6. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon. Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869 [TBL] [Abstract][Full Text] [Related]
7. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia. Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254 [TBL] [Abstract][Full Text] [Related]
8. Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics. Lennard L; Cartwright CS; Wade R; Vora A Br J Haematol; 2015 Apr; 169(2):228-40. PubMed ID: 25441457 [TBL] [Abstract][Full Text] [Related]
9. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia. Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026 [TBL] [Abstract][Full Text] [Related]
10. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. McLeod HL; Coulthard S; Thomas AE; Pritchard SC; King DJ; Richards SM; Eden OB; Hall AG; Gibson BE Br J Haematol; 1999 Jun; 105(3):696-700. PubMed ID: 10354134 [TBL] [Abstract][Full Text] [Related]
11. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872 [TBL] [Abstract][Full Text] [Related]
12. Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment. Kouwenberg TW; van den Bosch BJC; Bierau J; Te Loo DMWM; Coenen MJH; Hagleitner MM J Pediatr Hematol Oncol; 2020 Mar; 42(2):e94-e97. PubMed ID: 31895215 [TBL] [Abstract][Full Text] [Related]
13. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner. Kotur N; Dokmanovic L; Janic D; Stankovic B; Krstovski N; Tosic N; Katsila T; Patrinos GP; Zukic B; Pavlovic S Pharmacogenomics; 2015; 16(15):1701-12. PubMed ID: 26411491 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate binds to recombinant thiopurine S-methyltransferase and inhibits enzyme activity after high-dose infusions in childhood leukaemia. Wennerstrand P; Mårtensson LG; Söderhäll S; Zimdahl A; Appell ML Eur J Clin Pharmacol; 2013 Sep; 69(9):1641-9. PubMed ID: 23660772 [TBL] [Abstract][Full Text] [Related]
15. [Thiopurine S-methyltransferase gene sequence analysis of ALL children severely intolerant to 6-mercaptopurine]. Ma XL; Li WJ; Zheng J; Wang B; Jin M; Zhang DW; Li ZG; Zhang YX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):876-9. PubMed ID: 22931646 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia. Farfan MJ; Salas C; Canales C; Silva F; Villarroel M; Kopp K; Torres JP; Santolaya ME; Morales J BMC Cancer; 2014 Apr; 14():299. PubMed ID: 24774509 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia. Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698 [TBL] [Abstract][Full Text] [Related]
18. Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients. Jiménez-Morales S; Ramírez-Florencio M; Mejía-Aranguré JM; Núñez-Enríquez JC; Bekker-Mendez C; Torres-Escalante JL; Flores-Lujano J; Jiménez-Hernández E; Del Carmen Rodríguez-Zepeda M; Leal YA; González-Montalvo PM; Pantoja-Guillen F; Peñaloza-Gonzalez JG; Gutiérrez-Juárez EI; Núñez-Villegas NN; Pérez-Saldivar ML; Guerra-Castillo FX; Flores-Villegas LV; Ramos-Cervantes MT; Fragoso JM; García-Escalante MG; Del Carmen Pinto-Escalante D; Ramírez-Bello J; Hidalgo-Miranda A Arch Med Res; 2016 Nov; 47(8):615-622. PubMed ID: 28476189 [TBL] [Abstract][Full Text] [Related]
19. Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia. Tantawy AAG; Ebeid FSE; Adly AAM; El-Ghoroury E; Mostafa M J Genet; 2017 Dec; 96(6):905-910. PubMed ID: 29321348 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. McLeod HL; Krynetski EY; Relling MV; Evans WE Leukemia; 2000 Apr; 14(4):567-72. PubMed ID: 10764140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]